Live Longer. Live Better.
Start Now.

Epithalon (also known as Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) originally developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It works by stimulating the production of telomerase, the enzyme responsible for maintaining telomere length at the ends of chromosomes. As telomeres shorten with each cell division, cells lose their ability to replicate effectively. By activating telomerase, Epithalon supports the maintenance of telomere length, which is associated with cellular longevity and healthier aging. Research spanning 40+ years has demonstrated its role in normalizing circadian rhythms, melatonin production, and immune function.

No. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are oral precursors that your body must convert into NAD+ through multiple enzymatic steps, with significant losses during digestion and conversion. Injectable NAD+ delivers the active coenzyme directly into your bloodstream, bypassing the gut entirely for far superior bioavailability. This means faster onset, higher peak levels, and more reliable cellular energy restoration. Think of it this way: NMN and NR give your body the raw materials and hope it builds NAD+. Injectable NAD+ delivers the finished product directly where it's needed.

Topical GHK-Cu products primarily affect the skin at the application site, supporting local collagen production and wound healing. Injectable GHK-Cu, however, enters systemic circulation and can modulate gene expression throughout the body — over 4,000 genes according to published research. This systemic effect means injectable GHK-Cu supports tissue remodeling, anti-inflammatory pathways, and cellular repair across multiple organ systems, not just the skin. It's the difference between a localized cosmetic effect and a whole-body rejuvenation signal.

Absolutely. Many of our patients combine longevity and cognitive protocols for comprehensive optimization. In fact, several longevity peptides — particularly NAD+ and MOTS-C — have significant cognitive benefits as well. NAD+ supports neuronal energy metabolism and neuroprotection, while MOTS-C's metabolic benefits extend to brain function. Your prescribing physician will evaluate your goals and design a protocol that addresses both longevity and cognitive performance without unnecessary overlap or contraindication concerns.

Timeline varies by peptide and individual physiology. NAD+ often produces noticeable energy improvements within the first 1–2 weeks. MOTS-C benefits in metabolic efficiency and exercise capacity typically emerge within 2–4 weeks. Epithalon and GHK-Cu work at deeper cellular levels — telomere support and gene modulation — so their effects are more gradual, typically becoming apparent over 2–3 months of consistent use. Most patients report meaningful improvements in energy, sleep quality, and overall vitality within the first 30 days of a combined longevity protocol.

Not at all. While the effects of aging become more noticeable after 40, cellular decline begins much earlier. NAD+ levels start dropping in your 30s. Telomere shortening is continuous from birth. The most effective longevity strategy is proactive intervention before symptoms become obvious. Many of our patients in their 30s and 40s use longevity protocols to maintain peak cellular function, prevent age-related decline, and build a foundation for decades of healthspan. Think of it as preventive maintenance for your biology, not just damage repair.